Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Total cash & short-term investments

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndTotal cash & short-term investments (Million USD)YoY (%)
Dec 31, 20237+57.86%
Dec 31, 20224-86.14%
Dec 31, 202130+68.80%
Dec 31, 202018+193.00%
Dec 31, 20196-26.99%
Dec 31, 20188-28.24%
Dec 31, 201712+30.49%
Dec 31, 20169-23.72%
Dec 31, 201512-62.93%
Dec 31, 201432+2091.67%
Dec 31, 20131-43.37%
Dec 31, 20123-23.10%
Dec 31, 20113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)